Ono Pharmaceutical Co. (OPHLF)
(Delayed Data from OTC)
$14.47 USD
0.00 (0.00%)
Updated Apr 25, 2024 01:34 PM ET
4-Sell of 5 4
C Value B Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OPHLF 14.47 0.00(0.00%)
Will OPHLF be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for OPHLF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OPHLF
Ono Pharmaceutical Co. (OPHLF) Upgraded to Buy: Here's Why
New Strong Sell Stocks for June 2nd
OPHLF: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Reasons Why Ono Pharmaceutical Co. (OPHLF) Is a Great Growth Stock
Ono Pharmaceutical Co. (OPHLF) Upgraded to Strong Buy: What Does It Mean for the Stock?
Has Acadia Healthcare (ACHC) Outpaced Other Medical Stocks This Year?
Other News for OPHLF
Equillium Inc and Ono Pharmaceutical Co Ltd to Announce Exclusive Option and Asset Purchase ...
Ono Pharmaceutical GAAP EPS of ¥229.06, revenue of ¥389.91B